As we drive toward curing type 1 diabetes, we help make everyday life better for the people who face it.

Read all the updates from day 2 of Breakthrough T1D's Clinical and Research Congress focused entirely on type 1 diabetes.

A new clinical trial is investigating tegoprubart with islet cell transplants in people with type 1 diabetes and kidney disease.

A new clinical trial funded by Breakthrough T1D recently launched and is testing islet cell transplantation paired with Eledon Pharmaceuticals’ investigational immunosuppression therapy tegoprubart in ...

Hey Walker! We’re so excited to see you on October 25th 🙂 Check out the links below for important information: ...

Breakthrough T1D’s first-ever Clinical and Research Congress (CRC), focused entirely on type 1 diabetes (T1D), has come to a ...

The First Dual Glucose-Ketone Monitor is Approved in the U.S. You might have seen the news: the U.S. Food and Drug Administration approved Abbott’s Libre Duo 10 Day, the world’s first dual ...

PHILADELPHIA, Pa., Oct. 12, 2026 – Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces the conclusion of the inaugural Breakthrough ...

National Diabetes Awareness Month is the perfect time to see what’s next in type 1 diabetes (T1D) research. On Sunday, November 15, Breakthrough T1D invites you to a free research update at the ...

The Breakthrough T1D Youth Ambassador Program (YA) was designed to cultivate youth leaders within the type 1 diabetes (T1D) community. Youth Ambassadors inspire others by sharing their T1D stories, ...